{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T16:02:02Z","timestamp":1775836922809,"version":"3.50.1"},"reference-count":44,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Few environmental risk factors for ovarian cancer have been discovered. Women exposed to ionizing radiation from the atomic bomb during World War II experienced an increased risk of ovarian cancer. Today, the largest source of ionizing radiation is radon gas in the home, but whether ionizing radiation is associated with increased risk of ovarian cancer more broadly is unknown.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate whether higher home radon levels are associated with increased risk of ovarian cancer.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This prospective cohort study included 127\u202f547 women from the Women\u2019s Health Initiative, including 40 clinical centers across the US, with outcomes followed up for 31 years (1993-2024). Postmenopausal women aged 50 to 79 years were enrolled in an observational study or 1 or more randomized clinical trials. All cases of ovarian cancer were physician adjudicated.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Radon measurements from the 1993 US Geological Survey, classified into low (&amp;lt;2 pCi\/L), medium (2-4 pCi\/L), and high zones (&amp;gt;4 pCi\/L), were linked with the geocoded home addresses of participants at baseline (1993-1998).<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Hazard ratios (HRs) for ovarian cancer, adjusted for covariates with 95% CIs.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among the 127\u202f547 women (mean [SD] age, 63.1 [7.2] years) with available radon zone values, 1645 incident ovarian cancers and 1048 ovarian cancer deaths were observed over a mean (SD) follow-up of 17.7 (8.4) years. After adjustment for covariates, the HR for all ovarian cancers for women living in the medium radon zone compared with women living in the low radon zone was not significantly higher (HR, 1.13 [95% CI, 1.00-1.29]). However, the HR was significantly higher for women living in the high radon zone compared with those living in the low radon zone (HR, 1.31 [95% CI, 1.11-1.54]). Similar findings were observed for the most common histologic type, serous ovarian cancer, for which the HR in the medium zone was 1.06 (95% CI, 0.88-1.27) and the HR in the high zone was 1.38 (95% CI, 1.09-1.74). Ovarian cancer mortality also was significantly higher in the high radon zone compared with the low radon zone (HR, 1.31 [95% CI, 1.07-1.60]). Sensitivity analyses using 3 alternate radon measures produced similar results.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this large, prospective cohort of postmenopausal women, the risks of ovarian cancer incidence and mortality were significantly higher for women living in homes in the high radon zone. Residential radon is a ubiquitous and modifiable risk factor. This is the first epidemiologic study of radon and ovarian cancer among postmenopausal women to date, and its findings suggest a potential target for mitigating cancer risk.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.8641","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T15:31:11Z","timestamp":1775835071000},"page":"e268641","source":"Crossref","is-referenced-by-count":0,"title":["Residential Radon Levels and Ovarian Cancer Among Postmenopausal Women"],"prefix":"10.1001","volume":"9","author":[{"given":"Mark R.","family":"Williamson","sequence":"first","affiliation":[{"name":"Department of Population Health, School of Medicine & Health Sciences, University of North Dakota, Grand Forks"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Whitsel","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill"},{"name":"Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard L.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Statistics & Operations Research, Gillings School of Global Public Health, University of North Carolina, Chapel Hill"},{"name":"Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason M.","family":"Collins","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Stewart","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su Yon","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Fielding School of Public Health, Jonnson Comprehensive Cancer Center, University of California, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly R.","family":"Harris","sequence":"additional","affiliation":[{"name":"Program in Epidemiology, Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina Oktapodas","family":"Feiler","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JoAnn E.","family":"Manson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Harvard University, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihong","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Public Health, School of Medicine, University of California, Davis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary G.","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Department of Population Health, School of Medicine & Health Sciences, University of North Dakota, Grand Forks"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"issue":"5","key":"zoi260271r2","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1158\/0008-5472.CAN-19-2850","article-title":"The risk of ovarian cancer increases with an increase in the lifetime number of ovulatory cycles: an analysis from the Ovarian Cancer Cohort Consortium (OC3).","volume":"80","author":"Trabert","year":"2020","journal-title":"Cancer Res"},{"issue":"24","key":"zoi260271r3","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1200\/JCO.2016.66.8178","article-title":"Ovarian cancer risk factors by histologic subtype: an analysis from the Ovarian Cancer Cohort Consortium.","volume":"34","author":"Wentzensen","year":"2016","journal-title":"J Clin Oncol"},{"issue":"14","key":"zoi260271r4","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1001\/jama.2025.9495","article-title":"Ovarian cancer: a review.","volume":"334","author":"Caruso","year":"2025","journal-title":"JAMA"},{"issue":"30","key":"zoi260271r5","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1200\/JCO.23.01918","article-title":"Menopausal hormone therapy and ovarian and endometrial cancers: long-term follow-up of the Women\u2019s Health Initiative randomized trials.","volume":"42","author":"Chlebowski","year":"2024","journal-title":"J Clin Oncol"},{"issue":"3","key":"zoi260271r6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1667\/RR2629.1","article-title":"Studies of the mortality of atomic bomb survivors, report 14, 1950-2003: an overview of cancer and noncancer diseases.","volume":"177","author":"Ozasa","year":"2012","journal-title":"Radiat Res"},{"issue":"1","key":"zoi260271r7","first-page":"60","article-title":"Radiation risk of ovarian cancer in atomic bomb survivors: 1958-2009.","volume":"195","author":"Utada","year":"2021","journal-title":"Radiat Res"},{"key":"zoi260271r8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jenvrad.2018.05.017","article-title":"Radon and lung cancer: what does the public really know?","volume":"192","author":"Vogeltanz-Holm","year":"2018","journal-title":"J Environ Radioact"},{"issue":"4","key":"zoi260271r9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1088\/0952-4746\/22\/4\/304","article-title":"Doses to organs and tissues from radon and its decay products.","volume":"22","author":"Kendall","year":"2002","journal-title":"J Radiol Prot"},{"issue":"1","key":"zoi260271r10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3390\/ijms22010316","article-title":"Radon exposure\u2014therapeutic effect and cancer risk.","volume":"22","author":"Maier","year":"2020","journal-title":"Int J Mol Sci"},{"key":"zoi260271r11","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1439355","article-title":"Radon exposure and potential health effects other than lung cancer: a systematic review and meta-analysis.","volume":"12","author":"Henyoh","year":"2024","journal-title":"Front Public Health"},{"issue":"12","key":"zoi260271r12","first-page":"424","article-title":"The Women\u2019s Health Initiative clinical trial and observational study: history and overview.","volume":"77","author":"Assaf","year":"1994","journal-title":"R I Med"},{"issue":"4","key":"zoi260271r13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209143","article-title":"Radon exposure and incident stroke risk in the Women\u2019s Health Initiative.","volume":"102","author":"Buchheit","year":"2024","journal-title":"Neurology"},{"key":"zoi260271r16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1742-5573-3-8","article-title":"Accuracy of commercial geocoding: assessment and implications.","volume":"3","author":"Whitsel","year":"2006","journal-title":"Epidemiol Perspect Innov"},{"issue":"1","key":"zoi260271r21","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube.","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat Commun"},{"issue":"2","key":"zoi260271r22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1056\/NEJM200107123450205","article-title":"Neighborhood of residence and incidence of coronary heart disease.","volume":"345","author":"Diez Roux","year":"2001","journal-title":"N Engl J Med"},{"key":"zoi260271r23","doi-asserted-by":"publisher","DOI":"10.1214\/ss\/1009212411","article-title":"Analysis of local decisions using hierarchical modeling, applied to home radon measurement and remediation.","author":"Lin","year":"1999","journal-title":"Stat Sci"},{"issue":"2","key":"zoi260271r24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1158\/1055-9965.EPI-12-1050","article-title":"A comparison of the polytomous logistic regression and joint Cox proportional hazards models for evaluating multiple disease subtypes in prospective cohort studies.","volume":"22","author":"Xue","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"zoi260271r25","first-page":"2979","article-title":"Reduced ovarian cancer incidence in women exposed to low dose ionizing background radiation or radiation to the ovaries after treatment for breast cancer or rectosigmoid cancer.","volume":"17","author":"Lehrer","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"zoi260271r26","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s10552-013-0174-4","article-title":"Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies.","volume":"24","author":"Faber","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"7","key":"zoi260271r27","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1158\/1055-9965.EPI-18-1214","article-title":"Association between cigarette smoking and histotype-specific epithelial ovarian cancer: a review of epidemiologic studies.","volume":"28","author":"Zhou","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"zoi260271r28","doi-asserted-by":"publisher","first-page":"9993","DOI":"10.1038\/s41467-024-54444-2","article-title":"An umbrella review of socioeconomic status and cancer.","volume":"15","author":"Li","year":"2024","journal-title":"Nat Commun"},{"issue":"37","key":"zoi260271r29","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1038\/sj.onc.1206678","article-title":"Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation.","volume":"22","author":"Powell","year":"2003","journal-title":"Oncogene"},{"issue":"1","key":"zoi260271r30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1158\/1541-7786.MCR-06-0234","article-title":"Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.","volume":"5","author":"DelloRusso","year":"2007","journal-title":"Mol Cancer Res"},{"issue":"7716","key":"zoi260271r31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation\u2014a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"issue":"23","key":"zoi260271r32","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","article-title":"Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone.","volume":"90","author":"Risch","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"zoi260271r33","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1210\/er.2006-0036","article-title":"Gonadotropins and ovarian cancer.","volume":"28","author":"Choi","year":"2007","journal-title":"Endocr Rev"},{"key":"zoi260271r34","journal-title":"Cancer Res"},{"issue":"3","key":"zoi260271r35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2307\/3578712","article-title":"Southern blot and polymerase chain reaction exon analyses of HPRT\u2013 mutations induced by radon and radon progeny.","volume":"137","author":"Jostes","year":"1994","journal-title":"Radiat Res"},{"key":"zoi260271r36","doi-asserted-by":"publisher","DOI":"10.3390\/atmos14071132","author":"Yu","year":"2023","journal-title":"Atmosphere"},{"issue":"10","key":"zoi260271r37","doi-asserted-by":"publisher","DOI":"10.1289\/EHP14729","article-title":"Outdoor air pollution exposure and ovarian cancer incidence in a United States\u2013wide prospective cohort study.","volume":"132","author":"Ish","year":"2024","journal-title":"Environ Health Perspect"},{"key":"zoi260271r38","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2023.108141","article-title":"Ambient black carbon particles in human ovarian tissue and follicular fluid.","volume":"179","author":"Bongaerts","year":"2023","journal-title":"Environ Int"},{"issue":"8","key":"zoi260271r39","first-page":"301","article-title":"Effect of radon inhalation on serum gonadotropin and estrogen levels in postmenopausal women.","volume":"31","author":"Halawa","year":"1976","journal-title":"Pol Tyg Lek"},{"issue":"11","key":"zoi260271r40","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1007\/s00296-013-2819-8","article-title":"Long-term benefits of radon spa therapy in rheumatic diseases: results of the randomised, multi-centre IMuRa trial.","volume":"33","author":"Annegret","year":"2013","journal-title":"Rheumatol Int"},{"key":"zoi260271r42","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2020.144150","article-title":"A 10-year follow-up study of yearly indoor radon measurements in homes, review of other studies and implications on lung cancer risk estimates.","volume":"762","author":"Antignani","year":"2021","journal-title":"Sci Total Environ"},{"issue":"3","key":"zoi260271r43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2408084121","article-title":"High-resolution national radon maps based on massive indoor measurements in the United States.","volume":"122","author":"Li","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"key":"zoi260271r44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jenvrad.2020.106295","article-title":"A radon chamber specifically designed for environmentally relevant exposures of small animals.","volume":"220-221","author":"Puukila","year":"2020","journal-title":"J Environ Radioact"},{"key":"zoi260271r15","volume-title":"Geologic Radon Potential of EPA Regions 1-10","author":"Schumann","year":"1993"},{"key":"zoi260271r1","unstructured":"Ovarian cancer statistics & survival rates. Ovarian Cancer Research Alliance. Accessed August 15, 2025. https:\/\/ocrahope.org\/for-patients\/gynecologic-cancers\/ovarian-cancer\/ovarian-cancer-statistics\/"},{"key":"zoi260271r14","unstructured":"Radon zones map. US Environmental Protection Agency. 1993. Accessed October 22, 2024. https:\/\/www.epa.gov\/system\/files\/documents\/2024-05\/radon-zones-map_text_link.pdf"},{"key":"zoi260271r17","doi-asserted-by":"crossref","unstructured":"Duval? JS, Carson? JM, Holman? PB, Darnley? AG. Terrestrial radioactivity and gamma-ray exposure in the United States and Canada. Open-File Report 2005-1413. US Geological Survey; 2005. Accessed August 12, 2025. https:\/\/pubs.usgs.gov\/of\/2005\/1413\/","DOI":"10.3133\/ofr20051413"},{"key":"zoi260271r18","unstructured":"US Environmental Protection Agency; US Department of Housing and Urban Development; US Department of Health and Human Services; and Centers for Disease Control and Prevention. The National Radon Action Plan 2021-2025: eliminating preventable lung cancer from radon in the United States by expanding protections for all communities and buildings. Indoor Enivronments Association; AARST. January 31, 2022. Accessed March 9, 2026. https:\/\/aarst.org\/national-radon-action-plan-2021-25\/"},{"key":"zoi260271r19","unstructured":"Geologic maps of US states. US Geological Survey. 2017. Accessed October 2, 2024. https:\/\/mrdata.usgs.gov\/geology\/state\/"},{"key":"zoi260271r20","unstructured":"Data preparation and use of WHI investigator datasets. Women\u2019s Health Initiative. February 15, 2025. Accessed September 1, 2025. https:\/\/www.whi.org\/doc\/WHI_Data_Preparation_and_Use.pdf"},{"key":"zoi260271r41","unstructured":"AHS 2015 Public Use File (PUF). US Census Bureau. 2017. Accessed January 1, 2025. https:\/\/www.census.gov\/programs-surveys\/ahs\/data\/2015.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2847635\/williamson_2026_oi_260271_1775233639.52339.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T15:31:17Z","timestamp":1775835077000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2847635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.8641","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]}}}